NEXT

National Law Journal

Polster Sets Aggressive Discovery Schedule, Slating Opioid Trial for March 2019

With lawyers at an impasse over settling the national opioid litigation, a federal judge in Cleveland has set an aggressive discovery schedule that includes going to trial on March 18 of next year.
6 minute read

New Jersey Law Journal

J&J, Imerys Hit With $80M in Punitives Over Claims Linking Talc to Mesothelioma

Johnson & Johnson and Imerys Talc America were hit with an $80 million punitive damages verdict Wednesday in a suit by a New Jersey man who said he developed mesothelioma from using Johnson's Baby Powder. Total damages in the case rose to $117 million with the addition of today's verdict to last week's $37 million in compensatory damages.
7 minute read

Corporate Counsel

Health Care Fraud Recovery Dips to $2.6B, Federal Report Shows

Federal agencies recovered more than $2.6 billion in health care fraud and abuse judgments, settlements and impositions in 2017, according to a new annual report from the U.S. Department of Health and Human Services and the U.S. Department of Justice.
4 minute read

Daily Business Review

Palm Beach County Sues Drugmakers Over Opioid Crisis

“This case is about one thing: corporate greed,” the complaint said. “Defendants put their desire for profits above the health and well-being of Palm Beach County consumers.”
3 minute read

New Jersey Law Journal

Jurors in NJ Talc Trial Rejected J&J's Bid to Tarnish Plaintiffs' Scientific Evidence

In the nation's first trial where a jury linked Johnson & Johnson's talc products to mesothelioma, the company's efforts to discredit the plaintiffs' evidence simply fell flat.
4 minute read

Corporate Counsel

Health Care Tech, Biopharma Companies Get New Legal Execs

Waltham, Massachusetts-based Kala Pharmaceuticals, which currently is focused on technology to treat eye diseases, has named Eric Trachtenberg as general counsel and corporate secretary. SomaLogic Inc. of Boulder, Colorado, has appointed Melody Harris as the health tech company's chief legal officer.
3 minute read

New York Law Journal

McKesson Accused in New Filing of Skimming Excess Cancer Drugs for Profit

Pharmaceutical company McKesson Corp. and two of its subsidiaries engaged in a scheme to skim excess oncology drugs from prepackaged vials, a health care provider has alleged in a new complaint filed in Brooklyn federal court.
4 minute read

Delaware Business Court Insider

Drugmaker Moves to Block Generic Version of Anti-Opioid Suboxone

Indivior on Tuesday sued to block a rival drugmaker from bringing a generic version of an under-the-tongue form of Suboxone to market, after being dealt a stinging loss last month in an ongoing effort to protect its top-selling drug.
3 minute read

New York Law Journal

New York's Medical Marijuana Law Comes of Age

What originally was seen as one of the most restrictive medical marijuana laws in the country, viewed by some as so narrow and limited in scope that it was intended to fail, has evolved considerably as the atmosphere in the United States with regard to legal access to marijuana has changed.
8 minute read

New York Law Journal

Issuing Guidance on ESI Custodians, Court Defers to Responding Party

In their Federal E-Discovery column, H. Christopher Boehning & Daniel J. Toal write: 'In re EpiPen' breaks new ground on the standards for designating ESI custodians and, more broadly, on the proper scope of discovery under Federal Rule of Civil Procedure 26(b)(1). Judge James provides a clear and coherent set of principles for practitioners.
6 minute read

More from ALM

Resources

  • AI-Powered Deposition and Medical Record Summaries: Low Risk, High Reward

    Brought to you by Parrot

    Download Now

  • Aligning Client Needs with Lawyer Growth and Profitability

    Brought to you by BigHand

    Download Now

  • Technology to Make E-Discovery Smarter, Not Harder

    Brought to you by Nuix

    Download Now

  • Does Generative AI Have the Power to Transform Legal Services?

    Brought to you by HaystackID

    Download Now